Cantitate/Preț
Produs

Ethics and the Business of Biomedicine

Editat de Denis G. Arnold
en Limba Engleză Paperback – 10 iun 2009
During the last thirty years we have witnessed sweeping changes in health care worldwide, including new and expensive biomedical technologies, an increasingly powerful and influential pharmaceutical industry, steadily increasing health care costs in industrialised nations, and new threats to medical professionalism. The essays collected in this book concern costs and profits in relation to just health care, the often controversial practices of pharmaceutical companies, and corruption in the professional practice of medicine. Leading experts discuss justice in relation to business-friendly strategies in the delivery of health care, access to life saving drugs, the ethics of pharmaceutical company marketing practices, exploitation in drug trials, and undue industry influence over medicine. They offer guidance regarding the ethical delivery of health care products and services by profit-seeking organisations operating in a global marketplace, and recommend pragmatic solutions to enhance organisational integrity and curb medical corruption in the interest of patient welfare.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 25806 lei  6-8 săpt.
  Cambridge University Press – 10 iun 2009 25806 lei  6-8 săpt.
Hardback (1) 36547 lei  6-8 săpt.
  Cambridge University Press – 10 iun 2009 36547 lei  6-8 săpt.

Preț: 25806 lei

Nou

Puncte Express: 387

Preț estimativ în valută:
4939 5194$ 4114£

Carte tipărită la comandă

Livrare economică 03-17 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780521748223
ISBN-10: 0521748224
Pagini: 302
Dimensiuni: 152 x 228 x 15 mm
Greutate: 0.5 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:Cambridge, United Kingdom

Cuprins

Introduction, 1. Medicine and the market Daniel Callahan; 2. Broken promises: do business friendly strategies frustrate just health care? Norman Daniels; 3. Are patents an efficient and internationally fair means of funding research and development for new medicines? Paul Menzel; 4. The exploitation of the economically disadvantaged in pharmaceutical research disclosure Tom L. Beauchamp; 5. The dangers of detailing: how pharmaceutical marketing threatens health care Jason Hubbard; 6. The ethics of direct to consumer pharmaceutical advertising Denis G. Arnold; 7. Industry-funded bioethics and the limits of disclosure Carl Elliott; 8. Two cheers for the pharmaceutical industry Richard T. De George; 9. The third face of medicine: ethics and business and challenges to professionalism Mary V. Rorty, Patricia Werhane, and Ann Mills; 10. Theoretical foundations for an organizational ethics: developing norms for a new kind of health care George Khushf; 11. A crisis in medical professionalism: time for Flexner II Daniel Wikler; Bibliography; Index.

Recenzii

'The core norms of medicine as a profession are increasingly becoming infected with more business-oriented and profit-oriented norms. More and more so only patients are recognized as having rights to health care. One need not be a Marxist to have concerns about this state of affairs; it is sufficient to be a seriously ill and uninsured small business owner. Denis Arnold is to be commended for assembling an admirable collection of thoughtful essays aimed at prompting greater reflection on what the norms of medicine ought to be in a health care system with an undiagnosed obsessive-compulsive profit disorder.' Leonard M. Fleck, Michigan State University
'The health care system is a web of patients, physicians, third party payees, pharmaceutical companies, and hospitals. This collection of essays is a must for anyone interested in the justice and integrity of our health care system. Professor Arnold has done an outstanding job in bringing together many of the best minds in applied ethics to reflect on important ethical issues in the business of healthcare.' Norman E. Bowie, University of Minnesota
'Superbly edited by Denis G. Arnold, Ethics and the Business of Biomedicine combines academic rigor with up-to-date consideration of contemporary developments in the field of biomedicine. … makes an outstanding contribution to understanding the ethical implications of the deep transformations that are occurring in the financing and delivery of healthcare in the twenty-first century.' Business Ethics Quarterly

Descriere

Distinguished scholars of bioethics and business ethics discuss justice in relation to business-friendly strategies in the delivery of health care.